Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclopropofol for Prevention of Postoperative Nausea and Vomiting
NCT05837156Phase 1Unknown
- Start
- Aug 2023
- Primary completion
- Oct 2023
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of ciprofol in postoperative nausea and vomiting (PONV) (3 arms). Primary endpoint: Incidence of Postoperative Nausea and Vomiting within 24 hours. Status: unknown.
02
Drugs
ciprofol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05837156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05837156.